CN113122486B - Method for total biosynthesis of malonic acid - Google Patents

Method for total biosynthesis of malonic acid Download PDF

Info

Publication number
CN113122486B
CN113122486B CN201911420851.0A CN201911420851A CN113122486B CN 113122486 B CN113122486 B CN 113122486B CN 201911420851 A CN201911420851 A CN 201911420851A CN 113122486 B CN113122486 B CN 113122486B
Authority
CN
China
Prior art keywords
gene
plasmid
malonic acid
escherichia coli
dehydrogenase gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201911420851.0A
Other languages
Chinese (zh)
Other versions
CN113122486A (en
Inventor
邓禹
赵运英
李诗韵
李国辉
毛银
周胜虎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201911420851.0A priority Critical patent/CN113122486B/en
Publication of CN113122486A publication Critical patent/CN113122486A/en
Application granted granted Critical
Publication of CN113122486B publication Critical patent/CN113122486B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0016Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1096Transferases (2.) transferring nitrogenous groups (2.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/06Alanine; Leucine; Isoleucine; Serine; Homoserine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/08Lysine; Diaminopimelic acid; Threonine; Valine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/12Methionine; Cysteine; Cystine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/20Aspartic acid; Asparagine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/44Polycarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y103/00Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/99Oxidoreductases acting on the CH-CH group of donors (1.3) with other acceptors (1.3.99)
    • C12Y103/99001Succinate dehydrogenase (1.3.99.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y104/00Oxidoreductases acting on the CH-NH2 group of donors (1.4)
    • C12Y104/01Oxidoreductases acting on the CH-NH2 group of donors (1.4) with NAD+ or NADP+ as acceptor (1.4.1)
    • C12Y104/01021Aspartate dehydrogenase (1.4.1.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y206/00Transferases transferring nitrogenous groups (2.6)
    • C12Y206/01Transaminases (2.6.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y401/00Carbon-carbon lyases (4.1)
    • C12Y401/01Carboxy-lyases (4.1.1)
    • C12Y401/01031Phosphoenolpyruvate carboxylase (4.1.1.31)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y403/00Carbon-nitrogen lyases (4.3)
    • C12Y403/01Ammonia-lyases (4.3.1)
    • C12Y403/01001Aspartate ammonia-lyase (4.3.1.1), i.e. aspartase
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a method for total biosynthesis of malonic acid, and belongs to the technical field of bioengineering. The invention takes escherichia coli BL21 (DE 3) as a host, and the modules overexpress phosphoenolpyruvate carboxylase gene (ppc) from escherichia coli, succinate dehydrogenase gene (sdhC), succinic semialdehyde dehydrogenase gene (yne 1), asparaginase gene (aspa), heterologous gene aspartic acid-alpha-dehydrogenase gene (panD) from corynebacterium glutamicum, heterologous gene beta-alanine pyruvate transaminase gene (pa 0123) from pseudomonas aeruginosa, thus constructing a total biosynthesis path of malonic acid and enabling engineering bacteria to successfully accumulate malonic acid. The biological preparation of the malonic acid and the precursor thereof has the advantages of less pollution, high product quality and the like, and has great development prospect.

Description

Method for total biosynthesis of malonic acid
Technical Field
The invention relates to a method for total biosynthesis of malonic acid, and belongs to the field of bioengineering.
Background
Malonic acid (malonic acid; propanedioic acid; propane diacid) is also known as carrot acid, apple acid or beet acid. The molecular structure has two functional groups, namely active methylene and carboxyl, so that the molecular structure can participate in various chemical reactions, and is an important organic synthesis intermediate. It is mainly used in the aspects of perfume, adhesive, resin additive, medical intermediate, electroplating polishing agent, explosion control agent, heat welding fluxing additive, etc.
At present, the hydrolysis method of cyanoacetic acid and malonate is commonly used in industry to prepare malonic acid. However, the hydrolysis of cyanoacetic acid uses NaCN, while cyanide ions are extremely toxic, have great environmental hazard and have complex reaction process. The malonic ester is hydrolyzed mainly by directly hydrolyzing dimethyl (ethyl) malonate, wherein the malonic ester is also prepared into cyanoacetic acid through chloroacetic acid neutralization, cyanidation and other reactions, and then the malonic ester is produced by esterification, so that the method has great environmental hazard and complex reaction process. And the malonic acid obtained by the two methods needs to be subjected to complex and complicated purification procedures, so that the industrial production is limited.
In order to solve the above problems, people focus their eyes on the roads where malonic acid is biosynthesized. However, the study of the bio-production of malonic acid has progressed slowly due to lack of knowledge of suitable enzymes and metabolic pathways. Malonate semialdehyde is an important precursor of malonate, but this conversion is difficult due to the deletion of malonate semialdehyde dehydrogenase, and thus malonate bio-production proceeds slowly.
Disclosure of Invention
In order to solve the above problems, the present invention provides a recombinant E.coli producing malonic acid, which is based on E.coli BL21 (DE 3), and in which phosphoenolpyruvate carboxylase gene (ppc), succinate dehydrogenase gene (sdhC), succinic semialdehyde dehydrogenase gene (yne 1), asparaginase gene (aspA), heterologous gene aspartic acid-alpha-dehydrogenase gene (panD) from Corynebacterium glutamicum, and heterologous gene beta-alanine pyruvate transaminase gene (pa 0123) from Pseudomonas aeruginosa are expressed in a split manner.
In one embodiment of the invention, the split-module overexpression is to fuse and express genes yne1 and pa0123, fusion and express genes aspa and panD, and fusion and express genes sdhC and ppc.
In one embodiment, the nucleotide sequence of ppc is shown in SEQ ID NO.1 and the nucleotide sequence of sdhC is shown in SEQ ID NO. 2; the nucleotide sequence of aspA is shown as SEQ ID NO.3, and the nucleotide sequence of panD is shown as SEQ ID NO. 4; the nucleotide sequence of pa0123 is shown as SEQ ID NO.5, and the nucleotide sequence of yne1 is shown as SEQ ID NO. 6.
In one embodiment of the present invention, gene yne1, pa0123 uses pRSFDuet-1 as expression vector; the genes aspa and panD take pTrc99a as expression vectors; the gene fragments sdhC and ppc are expressed by pCDFDuet-1.
The invention also provides a method for constructing the recombinant escherichia coli, which comprises the following steps:
(1) The plasmid pRSFDuet-1 is used as a skeleton vector, and gene segments yne1 and pa0123 are connected to obtain a recombinant plasmid pRSF-yne1-pa0123;
(2) The plasmid pTrc99a is used as a skeleton vector, and gene fragments aspa and panD are connected to obtain a recombinant plasmid pTrc99a-aspa-panD;
(3) The plasmid pCDFDuet-1 is used as a skeleton vector to connect gene fragments sdhC and ppc to obtain recombinant plasmid pCDF-sdhC-ppc;
(4) pRSF-yne1-pa0123, pTrc99a-aspa-panD and pCDF-sdhC-ppc are transferred into escherichia coli BL21 (DE 3) together to obtain recombinant escherichia coli.
In one embodiment of the present invention, step (1) after the gene fragment pa0123 and the plasmid pRSFDuet-1 are digested with both Nco I and Hind III, they are digested with T 4 DNA ligase is connected to obtain recombinant plasmid pRSF-pa0123; treating both yne1 and recombinant plasmid pRSF-pa0123 with XhoI and Nde I, and then T 4 DNA ligase is used for connection to obtain recombinant plasmid pRSF-yne1-pa0123.
In one embodiment of the present invention, the gene fragment aspa and the plasmid pTrc99a are both digested with Sal I and Xho I, and then digested with T in step (2) 4 DNA ligase is connected to obtain recombinant plasmid pTrc99a-aspa; the panD and recombinant plasmid pTrc99a-aspa were treated with Xho I and Hind III double cleavage, followed by T 4 The DNA ligase was ligated to obtain the recombinant plasmid pTrc99a-aspa-panD.
In one embodiment of the present invention, step (3) after the gene fragment sdhC and the plasmid pCDFDuet-1 are both digested with Nco I and EcoR I, they are digested with T 4 DNA ligase is connected to obtain recombinant plasmid pCDF-sdhC; the ppc and recombinant plasmid pCDF-sdhC were treated with EcoR I and Sal I double cleavage and then T was used 4 The DNA ligase was ligated to obtain the recombinant plasmid pCDF-sdhC-ppc.
The third object of the invention is to provide a method for producing malonic acid by using the recombinant escherichia coli fermentation, which takes SOB culture medium as fermentation culture medium,culturing recombinant colibacillus at 35-37 deg.C until OD 600 1mM IPTG was added at 0.6-0.8 and the temperature was lowered to 30℃for induction culture for 48 hours.
In one embodiment of the invention, the SOB medium has a composition of 2g/100ml tryptone, 0.5g/100ml yeast powder, 0.05g/100ml NaCl,2.5mM KCl,10mM MgCl 2 0.8g/100ml glucose, 50. Mu.g/ml kanamycin sulfate, 50. Mu.g/ml ampicillin, 50. Mu.g/ml streptomycin.
In one embodiment of the invention, the seed solution is prepared by streaking the glycerol-deposited strain on a plate, picking a single colony, inoculating into a 250ml conical flask containing 50ml of LB liquid medium, shaking the flask overnight at 37℃at 250 rpm/min. Transferring 1ml of bacterial liquid into 50ml of LB liquid culture medium, culturing at 37 ℃ and 250rpm until reaching OD 600 When reaching 0.6-0.8, the strain is transferred to 50ml of SOB fermentation medium.
The invention also claims the use of said method for the preparation of malonic acid or its derivative products.
The beneficial effects are that: compared with a chemical method, the method for synthesizing malonic acid by using the escherichia coli full biological method firstly takes glucose as a precursor, can be developed in a sustainable way, and greatly reduces the pollution degree to the environment. The method for producing malonic acid by glucose fermentation is a high-yield way, provides environmental benefits by eliminating cyanide, chloroacetic acid and the like, does not need to use other compounds as a premise, can synthesize malonic acid by glucose by over-expressing 2 genes, namely a heterologous gene aspartic acid-alpha-dehydrogenase gene (panD) from corynebacterium glutamicum and a heterologous gene beta-alanine pyruvic transaminase gene (pa 0123) from pseudomonas aeruginosa, has simple method, mature fermentation process, enables escherichia coli BL21 (DE 3) to produce malonic acid at high yield, and has convenient operation, low cost and fermentation time of 48 hours of 0.23g/L.
Drawings
FIG. 1 shows the malonic acid synthesis pathway.
FIG. 2 is a pRSF-yne1-pa0123 plasmid map.
FIG. 3 is a map of pTrc99a-aspa-panD plasmid.
FIG. 4 is a map of pCDF-sdhC-ppc plasmid.
FIG. 5 is a map of pRSF-yne1-pa0123 plasmid colony pcr validation, 1: marker,2-5: colonies pcr, which were pRSF-yne1-pa0123, were validated for pa0123.
FIG. 6 is a graph showing the fermentation results of recombinant E.coli in SOB medium, IPTG 1 mM.
FIG. 7 is a liquid-phase mass spectrum detection spectrum of malonic acid; wherein (A) is a liquid phase diagram of a malonic acid standard sample and a liquid phase diagram only showing the malonic acid standard sample respectively; (B) Respectively a mass spectrum of a malonic acid standard sample and a mass spectrum which only displays malonic acid; (C) Respectively a liquid phase diagram of a fermentation broth sample and a liquid phase diagram only showing malonic acid in the fermentation broth; (D) Respectively a mass spectrum of a fermentation broth sample and a mass spectrum which only displays malonic acid in the fermentation broth; STANDARD is 1g/L STANDARD malonic acid sample, and PA is fermentation broth sample.
Detailed Description
Malonic acid liquid phase mass spectrum detection and result analysis:
pretreatment: and (3) centrifuging the fermentation sample at 12,000r/min for 2min to separate the fermentation liquor from the thalli, and treating the fermentation liquor by a 0.22 mu m filter membrane for detection by liquid phase mass spectrometry.
Liquid phase mass spectrometry conditions: detection wavelength: 200- - -400n, analytical column: BEH C18 (2.1x150mm 1.7um), column temperature 45 ℃, flow rate: sample injection amount of 0.3 ml/min: 5 μl, detector: waters Acquity PDA (200-400 nm).
The mobile phase conditions were as follows:
Figure BDA0002352346160000031
Figure BDA0002352346160000041
TABLE 1 primer sequence listing according to the following examples
Figure BDA0002352346160000042
Example 1: recombinant plasmid construction and recombinant escherichia coli acquisition.
The nucleotide sequences of ppc, sdhC, aspA, panD, pa0123 and yne1 are respectively shown in SEQ ID NO. 1-6.
The plasmid pRSFDuet-1 is digested with Nco I and Hind III, the target gene fragment pRSF-1 (3761 bp) is recovered by cutting gel, the plasmid pUC57-pa0123 synthesized by Jin Wei intelligent company is used as template, the primer pa0123-F/R is used for PCR amplification to obtain target gene fragment pa0123 (sequence is shown as SEQ ID NO. 5), then the two target fragments pRSF-1 and pa0123 are used for T 4 DNA ligase is connected, JM109 is transformed, positive transformants are picked up by colony PCR, plasmid digestion is extracted, PCR verification is carried out, the primer is veri-pRSF-F/R, and the plasmid after verification is named pRSF-pa0123.
The plasmid pRSF-pa0123 is digested with Xho I and Nde I, the target gene fragment pRSF-2 (5101 bp) is recovered by cutting, the same enzyme is used for cutting, the large intestine genome is used as template, the primer yne1-F/R is used for PCR amplification to obtain the yne1 fragment (shown as SEQ ID NO. 6), and then the two target fragments pRSF-2 and yne1 are used for T 4 DNA ligase is connected, JM109 is transformed, positive transformants are picked up by colony PCR, plasmid digestion and PCR verification are carried out, the primer is verified to be veri-pRSF-F/R, and the plasmid after verification is named pRSF-yne1-pa0123 (the plasmid diagram is shown in FIG. 2).
The plasmid pTrc99A is digested with Sal I and Xho I, the target vector DNA fragment pTrc99A-1 (4170 bp) is recovered by digestion, the same digestion is performed with the large intestine genome as template, the aspa fragment obtained by PCR amplification (as shown in SEQ ID NO. 3) is amplified with the primers aspa-F/R, and then the target fragments pTrc99A-1 and aspa are subjected to T 4 DNA ligase is connected, JM109 is transformed, positive transformants are picked up by colony PCR, plasmid digestion is extracted, PCR verification is carried out, the primer is veri-pTrc-F/R, and the plasmid after verification is named pTrc99a-aspa.
The plasmid pTrc99A-aspa is digested with Xho I and Hind III, the vector DNA fragment pTrc99A-2 (5622 bp) is recovered by cutting, the plasmid pUC57-panD synthesized by Jin Wei intelligent company is digested with the same enzyme as the template, the primers panD-F/R are used for PCR amplification to obtain the target gene fragment panD (shown as SEQ ID NO. 4),then T is used for two target fragments of pTrc99A-2 and panD 4 DNA ligase is connected, JM109 is transformed, positive transformants are picked up by colony PCR, plasmid digestion is extracted, PCR verification is carried out, the primers are veri-pTrc-F/R, and the plasmid after verification is named pTrc99a-aspa-panD (the plasmid diagram is shown in FIG. 3).
The plasmid pCDFDuet-1 was digested with Nco I and EcoRI, the target vector DNA fragment pCDF-1 (3744 bp) was recovered by digestion with the same enzyme, the large intestine genome was used as a template, the ppc fragment obtained by PCR amplification with the primer ppc-F/R (as shown in SEQ ID NO. 1) was amplified, and then the two target fragments pCDF-1 and ppc were subjected to T 4 DNA ligase is connected, JM109 is transformed, positive transformants are picked up by colony PCR, plasmid digestion and PCR verification are carried out, the primer is verified to be veri-pCDF-F/R, and the plasmid after verification is correctly named pCDF-ppc.
The target DNA fragment pCDF-2 (6379 bp) was recovered by double digestion of the plasmid pCDF-ppc with EcoR I and Sal I, digested with the same enzymes using the large intestine genome as a template, amplified by PCR with the primer sdhC-F/R to give the sdhC fragment (as shown in SEQ ID NO. 2), and then subjected to T-ligation with the two target fragments 4 DNA ligase is connected, JM109 is transformed, positive transformants are picked up by colony PCR, plasmid digestion and PCR verification are carried out, the primer is verified to be veri-pCDF-F/R, and the plasmid after verification is named pCDF-ppc-sdhC (the plasmid diagram is shown in FIG. 4).
pRSF-yne1-pa0123, pTrc99a-aspa-panD and pCDF-sdhC-ppc are transferred into competent cells of escherichia coli BL21 (DE 3) together to prepare recombinant escherichia coli.
Example 2: shake flask fermentation and result analysis of recombinant E.coli.
Fermentation medium: SOB culture medium with components of 20g/L tryptone, 5g/L yeast powder and 0.5g/LNaCl,2.5mM KCl,10mM MgCl 2 4g/L glucose, 50. Mu.g/ml kanamycin sulfate, 50. Mu.g/ml ampicillin, 50. Mu.g/ml streptomycin.
Seed liquid preparation: the glycerol-deposited strain was streaked on a plate, and single colonies were picked and inoculated into a 250ml Erlenmeyer flask containing 50ml of LB liquid medium, and shake flask at 37℃and 250rpm/min overnight.
Fermentation conditions:2% inoculum size (1 ml) inoculated into shake flask fermentation medium to give initial OD 600 0.1. Culturing at 37deg.C and 250r/min to OD 600 1.0mM IPTG was added at 0.8-1.0, and the temperature was changed to 30℃and the rpm/min for culturing.
Analysis of results: taking samples every 4H for the first 12H and every 12H for the last 60H, centrifuging at 12,000r/min for 5min to separate the fermentation liquid from thallus, and treating the fermentation liquid with 0.22 μm filter membrane for HPLC (high performance liquid chromatography) detection with mobile phase of 5mM H 2 SO 4 The column temperature was 30 ℃, differential detector. From the results of the liquid phase, no malonic acid production was detected for the first 24 hours, malonic acid production was detected from 36 hours, and the yield reached a maximum of 0.23g/L at 48 hours.
While the invention has been described with reference to the preferred embodiments, it is not limited thereto, and various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
SEQUENCE LISTING
<110> university of Jiangnan
<120> a method for total biosynthesis of malonic acid
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 2652
<212> DNA
<213> Escherichia coli
<400> 1
atgaacgaac aatattccgc attgcgtagt aatgtcagta tgctcggcaa agtgctggga 60
gaaaccatca aggatgcgtt gggagaacac attcttgaac gcgtagaaac tatccgtaag 120
ttgtcgaaat cttcacgcgc tggcaatgat gctaaccgcc aggagttgct caccacctta 180
caaaatttgt cgaacgacga gctgctgccc gttgcgcgtg cgtttagtca gttcctgaac 240
ctggccaaca ccgccgagca ataccacagc atttcgccga aaggcgaagc tgccagcaac 300
ccggaagtga tcgcccgcac cctgcgtaaa ctgaaaaacc agccggaact gagcgaagac 360
accatcaaaa aagcagtgga atcgctgtcg ctggaactgg tcctcacggc tcacccaacc 420
gaaattaccc gtcgtacact gatccacaaa atggtggaag tgaacgcctg tttaaaacag 480
ctcgataaca aagatatcgc tgactacgaa cacaaccagc tgatgcgtcg cctgcgccag 540
ttgatcgccc agtcatggca taccgatgaa atccgtaagc tgcgtccaag cccggtagat 600
gaagccaaat ggggctttgc cgtagtggaa aacagcctgt ggcaaggcgt accaaattac 660
ctgcgcgaac tgaacgaaca actggaagag aacctcggct acaaactgcc cgtcgaattt 720
gttccggtcc gttttacttc gtggatgggc ggcgaccgcg acggcaaccc gaacgtcact 780
gccgatatca cccgccacgt cctgctactc agccgctgga aagccaccga tttgttcctg 840
aaagatattc aggtgctggt ttctgaactg tcgatggttg aagcgacccc tgaactgctg 900
gcgctggttg gcgaagaagg tgccgcagaa ccgtatcgct atctgatgaa aaacctgcgt 960
tctcgcctga tggcgacaca ggcatggctg gaagcgcgcc tgaaaggcga agaactgcca 1020
aaaccagaag gcctgctgac acaaaacgaa gaactgtggg aaccgctcta cgcttgctac 1080
cagtcacttc aggcgtgtgg catgggtatt atcgccaacg gcgatctgct cgacaccctg 1140
cgccgcgtga aatgtttcgg cgtaccgctg gtccgtattg atatccgtca ggagagcacg 1200
cgtcataccg aagcgctggg cgagctgacc cgctacctcg gtatcggcga ctacgaaagc 1260
tggtcagagg ccgacaaaca ggcgttcctg atccgcgaac tgaactccaa acgtccgctt 1320
ctgccgcgca actggcaacc aagcgccgaa acgcgcgaag tgctcgatac ctgccaggtg 1380
attgccgaag caccgcaagg ctccattgcc gcctacgtga tctcgatggc gaaaacgccg 1440
tccgacgtac tggctgtcca cctgctgctg aaagaagcgg gtatcgggtt tgcgatgccg 1500
gttgctccgc tgtttgaaac cctcgatgat ctgaacaacg ccaacgatgt catgacccag 1560
ctgctcaata ttgactggta tcgtggcctg attcagggca aacagatggt gatgattggc 1620
tattccgact cagcaaaaga tgcgggagtg atggcagctt cctgggcgca atatcaggca 1680
caggatgcat taatcaaaac ctgcgaaaaa gcgggtattg agctgacgtt gttccacggt 1740
cgcggcggtt ccattggtcg cggcggcgca cctgctcatg cggcgctgct gtcacaaccg 1800
ccaggaagcc tgaaaggcgg cctgcgcgta accgaacagg gcgagatgat ccgctttaaa 1860
tatggtctgc cagaaatcac cgtcagcagc ctgtcgcttt ataccggggc gattctggaa 1920
gccaacctgc tgccaccgcc ggagccgaaa gagagctggc gtcgcattat ggatgaactg 1980
tcagtcatct cctgcgatgt ctaccgcggc tacgtacgtg aaaacaaaga ttttgtgcct 2040
tacttccgct ccgctacgcc ggaacaagaa ctgggcaaac tgccgttggg ttcacgtccg 2100
gcgaaacgtc gcccaaccgg cggcgtcgag tcactacgcg ccattccgtg gatcttcgcc 2160
tggacgcaaa accgtctgat gctccccgcc tggctgggtg caggtacggc gctgcaaaaa 2220
gtggtcgaag acggcaaaca gagcgagctg gaggctatgt gccgcgattg gccattcttc 2280
tcgacgcgtc tcggcatgct ggagatggtc ttcgccaaag cagacctgtg gctggcggaa 2340
tactatgacc aacgcctggt agacaaagca ctgtggccgt taggtaaaga gttacgcaac 2400
ctgcaagaag aagacatcaa agtggtgctg gcgattgcca acgattccca tctgatggcc 2460
gatctgccgt ggattgcaga gtctattcag ctacggaata tttacaccga cccgctgaac 2520
gtattgcagg ccgagttgct gcaccgctcc cgccaggcag aaaaagaagg ccaggaaccg 2580
gatcctcgcg tcgaacaagc gttaatggtc actattgccg ggattgcggc aggtatgcgt 2640
aataccggct aa 2652
<210> 2
<211> 390
<212> DNA
<213> Escherichia coli
<400> 2
atgataagaa atgtgaaaaa acaaagacct gttaatctgg acctacagac catccggttc 60
cccatcacgg cgatagcgtc cattctccat cgcgtttccg gtgtgatcac ctttgttgca 120
gtgggcatcc tgctgtggct tctgggtacc agcctctctt cccctgaagg tttcgagcaa 180
gcttccgcga ttatgggcag cttcttcgtc aaatttatca tgtggggcat ccttaccgct 240
ctggcgtatc acgtcgtcgt aggtattcgc cacatgatga tggattttgg ctatctggaa 300
gaaacattcg aagcgggtaa acgctccgcc aaaatctcct ttgttattac tgtcgtgctt 360
tcacttctcg caggagtcct cgtatggtaa 390
<210> 3
<211> 1437
<212> DNA
<213> Escherichia coli
<400> 3
atgtcaaaca acattcgtat cgaagaagat ctgttgggta ccagggaagt tccagctgat 60
gcctactatg gtgttcacac tctgagagcg attgaaaact tctatatcag caacaacaaa 120
atcagtgata ttcctgaatt tgttcgcggt atggtaatgg ttaaaaaagc cgcagctatg 180
gcaaacaaag agctgcaaac cattcctaaa agtgtagcga atgccatcat tgccgcatgt 240
gatgaagtcc tgaacaacgg aaaatgcatg gatcagttcc cggtagacgt ctaccagggc 300
ggcgcaggta cttccgtaaa catgaacacc aacgaagtgc tggccaatat cggtctggaa 360
ctgatgggtc accaaaaagg tgaatatcag tacctgaacc cgaacgacca tgttaacaaa 420
tgtcagtcca ctaacgacgc ctacccgacc ggtttccgta tcgcagttta ctcttccctg 480
attaagctgg tagatgcgat taaccaactg cgtgaaggct ttgaacgtaa agctgtcgaa 540
ttccaggaca tcctgaaaat gggtcgtacc cagctgcagg acgcagtacc gatgaccctc 600
ggtcaggaat tccgcgcttt cagcatcctg ctgaaagaag aagtgaaaaa catccaacgt 660
accgctgaac tgctgctgga agttaacctt ggtgcaacag caatcggtac tggtctgaac 720
acgccgaaag agtactctcc gctggcagtg aaaaaactgg ctgaagttac tggcttccca 780
tgcgtaccgg ctgaagacct gatcgaagcg acctctgact gcggcgctta tgttatggtt 840
cacggcgcgc tgaaacgcct ggctgtgaag atgtccaaaa tctgtaacga cctgcgcttg 900
ctctcttcag gcccacgtgc cggcctgaac gagatcaacc tgccggaact gcaggcgggc 960
tcttccatca tgccagctaa agtaaacccg gttgttccgg aagtggttaa ccaggtatgc 1020
ttcaaagtca tcggtaacga caccactgtt accatggcag cagaagcagg tcagctgcag 1080
ttgaacgtta tggagccggt cattggccag gccatgttcg aatccgttca cattctgacc 1140
aacgcttgct acaacctgct ggaaaaatgc attaacggca tcactgctaa caaagaagtg 1200
tgcgaaggtt acgtttacaa ctctatcggt atcgttactt acctgaaccc gttcatcggt 1260
caccacaacg gtgacatcgt gggtaaaatc tgtgccgaaa ccggtaagag tgtacgtgaa 1320
gtcgttctgg aacgcggtct gttgactgaa gcggaacttg acgatatttt ctccgtacag 1380
aatctgatgc acccggctta caaagcaaaa cgctatactg atgaaagcga acagtaa 1437
<210> 4
<211> 411
<212> DNA
<213> Corynebacterium glutamicum
<400> 4
atgttgcgta ctatcctggg ctccaaaatt catcgtgcca ccgtcacgca ggcagacttg 60
gattatgtgg gctccgtgac catcgacgcg gacttagtcc acgccgccgg gttgatcgaa 120
ggcgagaaag tggcgattgt agacattacc aacggggctc gcttggaaac ttatgtcatt 180
gtgggtgatg cgggaactgg gaacatctgc attaacgggg ccgcagctca tctgatcaat 240
ccgggcgatt tggtgatcat catgtcatat ttgcaagcga cggatgcaga agctaaagca 300
tatgagccga agatcgtcca tgtcgacgct gataaccgca ttgtggcgct gggaaacgac 360
ctggctgagg ccttgccagg ttcaggcctt ttaaccagtc gctcgatcta g 411
<210> 5
<211> 1347
<212> DNA
<213> Pseudomona aeruginosa
<400> 5
atgaatcagc ccctgaatgt cgctccgccc gtgagctcgg aattaaacct gcgcgcccac 60
tggatgccat tttcggctaa ccgcaatttc caaaaagacc cgcgtattat cgtcgcggcg 120
gagggctcct ggctgaccga cgacaagggc cgtaaagtat acgatagcct gtcaggatta 180
tggacctgcg gtgcggggca tagccgcaag gaaattcagg aagcggttgc tcgtcaactg 240
gggactttgg actattcgcc aggattccaa tatggacatc cattgtcttt ccagttggcc 300
gagaagattg ctgggttatt acctggggaa ttaaaccatg tcttttttac gggatcaggg 360
tcggagtgcg cagacacttc gattaagatg gcccgcgcct actggcgctt aaagggacaa 420
ccccagaaga ctaagctgat tggacgcgca cgcggttacc acggcgtgaa tgtcgcgggc 480
acaagccttg gagggatcgg ggggaaccgc aagatgttcg gacagctgat ggatgtggac 540
catcttcccc atacccttca gccaggtatg gcattcactc gcgggatggc gcagacagga 600
ggcgttgaac tggcgaatga gttattaaag ttaattgaat tgcacgatgc gtctaacatc 660
gcagcggtta ttgtcgagcc catgtccggt tccgcaggag ttttagtgcc acccgtgggc 720
tatctgcagc gtttgcgcga aatctgtgac caacacaata ttctgcttat ctttgatgaa 780
gtgattacgg ctttcgggcg tctgggtact tactcgggag ccgaatactt cggggtcacg 840
ccggacttga tgaatgttgc aaaacaggtc acgaatggtg cagtacctat gggtgctgta 900
atcgcctcta gcgagattta cgatactttc atgaaccagg cgctgcctga acatgcggtt 960
gaattttccc acggttatac atattcagcg cacccagtgg catgtgctgc gggattagca 1020
gcactggaca tcttggcgcg cgataactta gtacagcagt cagcagagtt agctccacac 1080
ttcgagaagg gattgcatgg ccttcaaggt gccaagaatg ttatcgacat tcgcaactgc 1140
ggcttagcag gcgcgatcca gatcgctccc cgtgatgggg atccgacagt tcgccccttt 1200
gaagccggga tgaaactgtg gcaacaaggg ttttacgtcc gtttcggcgg cgacactctg 1260
cagtttgggc caacatttaa tgcacgccca gaggaattgg accgtctttt tgacgctgta 1320
ggtgaggctc tgaacggaat tgcctga 1347
<210> 6
<211> 1149
<212> DNA
<213> Escherichia coli
<400> 6
aaaccaatca accaggcgcg cgctgaagtg gcgaaatcgg cgaatttgtg tgactggtat 60
gcagaacatg gtccggcaat gctgaaggcg gaacctacgc tggtggaaaa tcagcaggcg 120
gttattgagt atcgaccgtt ggggacgatt ctggcgatta tgccgtggaa ttttccgtta 180
tggcaggtga tgcgtggcgc tgttcccatc attcttgcag gtaacggcta cttacttaaa 240
catgcgccga atgtgatggg ctgtgcacag ctcattgccc aggtgtttaa agatgcgggt 300
atcccacaag gcgtatatgg ctggctgaat gccgacaacg acggtgtcag tcagatgatt 360
aaagactcgc gcattgctgc tgtcacggtg accggaagtg ttcgtgcggg agcggctatt 420
ggcgcacagg ctggagcggc actgaaaaaa tgcgtactgg aactgggcgg ttcggatccg 480
tttattgtgc ttaacgatgc cgatctggaa ctggcggtga aagcggcggt agccggacgt 540
tatcagaata ccggacaggt atgtgcagcg gcaaaacgct ttattatcga agagggaatt 600
gcttcggcat ttaccgaacg ttttgtggca gctgcggcag ccttgaaaat gggcgatccc 660
cgtgacgaag agaacgctct cggaccaatg gctcgttttg atttacgtga tgagctgcat 720
catcaggtgg agaaaaccct ggcgcagggt gcgcgtttgt tactgggcgg ggaaaagatg 780
gctggggcag gtaactacta tccgccaacg gttctggcga atgttacccc agaaatgacc 840
gcgtttcggg aagaaatgtt tggccccgtt gcggcaatca ccattgcgaa agatgcagaa 900
catgcactgg aactggctaa tgatagtgag ttcggccttt cagcgaccat ttttaccact 960
gacgaaacac aggccagaca gatggcggca cgtctggaat gcggtggggt gtttatcaat 1020
ggttattgtg ccagcgacgc gcgagtggcc tttggtggcg tgaaaaagag tggctttggt 1080
cgtgagcttt cccatttcgg cttacacgaa ttctgtaata tccagacggt gtggaaagac 1140
cggatctga 1149

Claims (7)

1. A recombinant escherichia coli for producing malonic acid is characterized in that escherichia coli BL21 (DE 3) is taken as a host, and phosphoenolpyruvate carboxylase gene, succinic dehydrogenase gene, succinic semialdehyde dehydrogenase gene and asparaginase gene from escherichia coli, heterologous gene aspartic acid-alpha-dehydrogenase gene from corynebacterium glutamicum and beta-alanine pyruvic transaminase gene from pseudomonas aeruginosa are subjected to modular overexpression;
the split-module overexpression is to fuse and express a succinic semialdehyde dehydrogenase gene and a beta-alanine pyruvic transaminase gene, fuse and express an asparaginase gene and an aspartic acid-alpha-dehydrogenase gene, and fuse and express a succinic dehydrogenase gene and a phosphoenolpyruvic carboxylase gene;
the nucleotide sequence of the phosphoenolpyruvate carboxylase gene is shown as SEQ ID NO.1, and the nucleotide sequence of the succinate dehydrogenase gene is shown as SEQ ID NO. 2; the nucleotide sequence of the asparaginase gene is shown as SEQ ID NO.3, and the nucleotide sequence of the aspartic acid-alpha-dehydrogenase gene is shown as SEQ ID NO. 4; the nucleotide sequence of the beta-alanine pyruvic transaminase gene is shown as SEQ ID NO.5, and the nucleotide sequence of the succinic semialdehyde dehydrogenase gene is shown as SEQ ID NO. 6;
the plasmid pRSFDuet-1 is used as skeleton carrier to connect gene segment succinic semialdehyde dehydrogenase geneyne1Beta-alanine pyruvic transaminase genepa0123The method comprises the steps of carrying out a first treatment on the surface of the The plasmid pTrc99a is used as skeleton carrier to connect gene segment asparaginase geneaspaAspartic acid-alpha-dehydrogenase genepanDThe method comprises the steps of carrying out a first treatment on the surface of the The plasmid pCDFDuet-1 is used as a skeleton carrier to connect gene segment succinic dehydrogenase genesdhCPhosphoenolpyruvate carboxylase geneppc
2. A method of constructing the recombinant escherichia coli of claim 1, comprising the steps of:
(1) The plasmid pRSFDuet-1 is used as a skeleton vector to connect gene fragmentsyne1pa0123Obtaining recombinant plasmid pRSF-yne1-pa0123;
(2) The plasmid pTrc99a is used as skeleton carrier to connect gene fragmentaspapanDObtaining recombinant plasmid pTrc99a-aspa-panD;
(3) The plasmid pCDFDuet-1 is used as a skeleton vector to connect gene fragmentssdhCppcObtaining recombinant plasmid pCDF-sdhC-ppc;
(4) pRSF-yne1-pa0123, pTrc99a-aspa-panD and pCDF-sdhC-ppc are transferred into escherichia coli BL21 (DE 3) together to obtain recombinant escherichia coli.
3. A method for producing malonic acid, wherein the recombinant escherichia coli of claim 1 is inoculated into a fermentation medium containing glucose for fermentation to produce malonic acid.
4. A method according to claim 3, characterized in that the recombination is performedE.coli is cultivated at 35-37 ℃ until OD 600 At 0.6-0.8, IPTG was added for induction.
5. The method of claim 4, wherein the induction is at 28-30 ℃ for 36-60 hours.
6. The method according to any one of claims 3 to 5, wherein SOB medium is used as fermentation medium,
7. use of the recombinant escherichia coli of claim 1 or the method of any one of claims 3-6 for preparing malonic acid.
CN201911420851.0A 2019-12-31 2019-12-31 Method for total biosynthesis of malonic acid Active CN113122486B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911420851.0A CN113122486B (en) 2019-12-31 2019-12-31 Method for total biosynthesis of malonic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911420851.0A CN113122486B (en) 2019-12-31 2019-12-31 Method for total biosynthesis of malonic acid

Publications (2)

Publication Number Publication Date
CN113122486A CN113122486A (en) 2021-07-16
CN113122486B true CN113122486B (en) 2023-06-13

Family

ID=76769533

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911420851.0A Active CN113122486B (en) 2019-12-31 2019-12-31 Method for total biosynthesis of malonic acid

Country Status (1)

Country Link
CN (1) CN113122486B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113817782B (en) * 2021-09-27 2023-08-25 江南大学 Full biosynthesis method of pimelic acid
CN114736841B (en) * 2022-04-02 2023-12-19 万华化学集团股份有限公司 Recombinant escherichia coli as well as preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256314A (en) * 1998-12-01 2000-06-14 底古萨-胡尔斯股份公司 Fermentation process for preparing D-pantothenic acid by amplifying PAND gene in microbe
CN107787361A (en) * 2015-03-20 2018-03-09 韩国科学技术院 Generate the mutant microbial of L aspartames and the method using mutant microbial generation L aspartames
CN108884464A (en) * 2016-01-11 2018-11-23 韩国科学技术院 The method for generating the recombination mutation microorganism of ability with malonic acid and generating malonic acid using it
CN110592153A (en) * 2014-06-23 2019-12-20 Cj第一制糖株式会社 Microorganism producing O-acetylhomoserine and method for producing O-acetylhomoserine using the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256314A (en) * 1998-12-01 2000-06-14 底古萨-胡尔斯股份公司 Fermentation process for preparing D-pantothenic acid by amplifying PAND gene in microbe
CN110592153A (en) * 2014-06-23 2019-12-20 Cj第一制糖株式会社 Microorganism producing O-acetylhomoserine and method for producing O-acetylhomoserine using the same
CN107787361A (en) * 2015-03-20 2018-03-09 韩国科学技术院 Generate the mutant microbial of L aspartames and the method using mutant microbial generation L aspartames
CN108884464A (en) * 2016-01-11 2018-11-23 韩国科学技术院 The method for generating the recombination mutation microorganism of ability with malonic acid and generating malonic acid using it

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Metabolic Engineering of Escherichia coli for the Production of 3‑Hydroxypropionic Acid and Malonic Acid through β‑Alanine Route;Chan Woo Song等;《ACS Synthetic Biology》;20160229;第5卷;摘要,第1257页右栏第4段,图1,第1258页左栏第2段,右栏第2段,第1259页右栏第2段,第1261页表1 *

Also Published As

Publication number Publication date
CN113122486A (en) 2021-07-16

Similar Documents

Publication Publication Date Title
CN106957850B (en) Genetically engineered bacterium for producing phospholipase D and construction method and application thereof
CN105647844B (en) Recombinant bacterium for producing glycolic acid by using xylose and construction method and application thereof
CN109890960B (en) Process for producing aldehyde
CN113122486B (en) Method for total biosynthesis of malonic acid
KR20220139351A (en) Modified Microorganisms and Methods for Improved Production of Ectoins
CN110904018B (en) 5-aminolevulinic acid production strain and construction method and application thereof
CN111471638A (en) Construction and application of corynebacterium glutamicum mutant strain capable of producing L-homoserine
KR20190025969A (en) A method for the fermentative production of a molecule of interest by a microorganism comprising a gene encoding a sugar phosphotransferase system (PTS)
CN107384847B (en) Recombinant bacterium for producing ethylene glycol by efficiently converting xylose and application thereof
CN113817782B (en) Full biosynthesis method of pimelic acid
CN114540261B (en) Gene engineering bacteria for producing amino adipic acid
CN113151337A (en) Method for expressing trehalose synthase by using EF-Tu promoter in corynebacterium glutamicum and application
CN114806913B (en) High-yield succinic acid yeast engineering strain with mitochondria positioning reduction TCA pathway, construction method and application thereof
CN113583925B (en) Method for preparing patchouli alcohol by fermenting metabolic engineering escherichia coli
CN113563435B (en) Protein for promoting production of poly-3-hydroxybutyrate from ralstonia eutropha and application thereof
CN113832087B (en) Method for total biosynthesis of malonic acid by using escherichia coli
US10501745B2 (en) Promoter and use thereof
CN113025541B (en) Engineering bacterium for synthesizing salicin and construction method and application thereof
CN108884465B (en) Modified microorganism having acrylic acid-producing ability and method for producing acrylic acid using the same
CN114736841B (en) Recombinant escherichia coli as well as preparation method and application thereof
CN114381412B (en) Recombinant bacterium for synthesizing 3-hydroxy propionic acid and construction method and application thereof
CN112011523B (en) Acetylacetone lyase mutant capable of improving acetylacetone synthesis efficiency, gene, expression vector, cell and application thereof
CN115029329B (en) Carbonyl reductase mutant and application thereof in preparation of R-mandelic acid
US20240052382A1 (en) Process control for 3-hydroxypropionic acid production by engineered strains of aspergillus niger
CN114958890A (en) Method for constructing genetic engineering strain for stable genetic salicylic acid biosynthesis and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant